GlassScriptPhysician profile
George Robert Kaftan
NPI 1710913991
$3,201.89
in general payments reported to CMS, 2019-2025
38 companies · $621 in 2025
The $621 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $63.82 · 2021: $186 · 2022: $459 · 2023: $722 · 2024: $724 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,066.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $915.53 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $461.28 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $245.71 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $207.80 | 2019-2025 | |
| Lilly USA, LLC | $139.93 | 2019-2024 | Mounjaro |
| Tandem Diabetes Care, INC. | $111.68 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Exact Sciences Corporation | $104.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $84.62 | 2022-2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $61.30 | 2023-2024 | Gvoke Hypopen |
| Amgen INC. | $54.91 | 2019-2023 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $54.42 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.41 | 2021-2024 | Xifaxan, Trulance |
| Sanofi Pasteur INC. | $52.01 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.52 | 2019-2024 | |
| Axsome Therapeutics, INC. | $47.44 | 2025 | Auvelity |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Kaftan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.